Tiagabine and other anticonvulsants with actions on GABA

Journal of Clinical Psychiatry

Volumn 65, Issue 3, 2004, Pages 291-292

  Stahl, Stephen M ^a,b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; DRUG DERIVATIVE; FRUCTOSE; LAMOTRIGINE; NIPECOTIC ACID DERIVATIVE; TIAGABINE; TOPIRAMATE; TRIAZINE DERIVATIVE; VALPROIC ACID;

ANXIETY DISORDER; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SYNAPSE;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANXIETY DISORDERS; CARBAMAZEPINE; FRUCTOSE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NIPECOTIC ACIDS; SYNAPSES; TRIAZINES; VALPROIC ACID;

EID: 2342457689     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0301     Document Type: Review

References (24)

1. Stahl SM. Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action? [BRAINSTORMS] J Clin Psychiatry 2004;59:149-150
2. Stahl SM. Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents [BRAINSTORMS]. J Clin Psychiatry 2002;63:854-855 (Pubitemid 35231724)
3. Coplan JD, Lydiard RB. Brain circuits in panic disorder. Biol Psychiatry 1998;44:1264-1276 (Pubitemid 29015864)
4. Stutzmann GE, LeDoux JE. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs to fear conditioning. J Neurosci 1999;19:RC8
5. Stahl SM. Essential psychopharmacology of depression and bipolar disorder. 2nd ed. New York, NY: Cambridge University Press; 2002
6. Borden LA, Murali Dhar TG, Smith KE, et al. Tiagabine, SK and F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 1994;269:219-224 (Pubitemid 24316081)
7. Borden LA. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem Int 1996;29:335-356
8. Minelli A, Brecha NC, Karschin C, et al. GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci 1995;15:7734-7746
9. Connor K, Weisler R, Zhang W, et al. Tiagabine for posttraumatic stress disorder. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 22, 2003; San Francisco, Calif. Abstract NR822:307
10. Papp L, Ray S. Tiagabine treatment of generalized anxiety disorder. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 22, 2003; San Francisco, Calif. Abstract NR818:306
11. Rosenthal M. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. J Clin Psychiatry 2003;64:1245-1249
12. Crane D. Tiagabine for the treatment of anxiety. Depress Anxiety 2003;18:51-52 (Pubitemid 37012936)
13. Schwartz TL. The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series. Psychopharmacol Bull 2002;36:53-57
14. Schwartz TL, Nouman A, Husain J, et al. Tiagabine as augmentation therapy for anxiety. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 19, 2003; San Francisco, Calif. Abstract NR258:96-97
15. Taylor FB III. Tiagabine for the treatment of posttraumatic stress disorder. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 22, 2003; San Francisco, Calif. Abstract NR772:289
16. Carpenter L, Tyrka A, Schecter J, et al. Tiagabine for major depression with anxiety. In: New Research Abstracts of the156th Annual Meeting of the American Psychiatric Association; May 20, 2003; San Francisco, Calif. Abstract NR501:187
17. Zwanzger P, Baghai TC, Schüle C, et al. Tiagabine improves panic and agoraphobia in panic disorder patients [letter]. J Clin Psychiatry 2001;62:656-657 (Pubitemid 32848174)
18. Sills GJ. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Epil Disord 2003;5:51-56 (Pubitemid 36604249)
19. Zwanzger P, Baghai TC, Schuele C, et al. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology 2001;25:699-703 (Pubitemid 32995952)
20. Baetz M, Bowen RC. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry Rev Canadienne de Psychiatrie 1998;43:73-77 (Pubitemid 28125133)
21. Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999;45:1226-1229 (Pubitemid 29236566)
22. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 2002;63:15-20 (Pubitemid 34113481)
23. Clark RD, Canive JM, Calais LA, et al. Divalproex in posttraumatic stress disorder: an open-label clinical trial. J Trauma Stress 1999;12:395-401 (Pubitemid 29279497)
24. Uhde TW, Stein MB, Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry 1988;145:1104-1109 (Pubitemid 18216360)